Lamp2a is required for tumor growth and promotes tumor recurrence of hepatocellular carcinoma

Ding,Zhen-Bin; Fu,Xiu-Tao; Shi,Ying-Hong; Zhou,Jian; Peng,Yuan-Fei; Liu,Wei-Ren; Shi,Guo-Ming; Gao,Qiang; Wang,Xiao-Ying; Song,Kang; Jin,Lei; Tian,Meng-Xin; Shen,Ying-Hao; Fan,Jia

doi:10.3892/ijo.2016.3754

Lamp2a is required for tumor growth and promotes tumor recurrence of hepatocellular carcinoma

Authors:
- Zhen-Bin Ding
- Xiu-Tao Fu
- Ying-Hong Shi
- Jian Zhou
- Yuan-Fei Peng
- Wei-Ren Liu
- Guo-Ming Shi
- Qiang Gao
- Xiao-Ying Wang
- Kang Song
- Lei Jin
- Meng-Xin Tian
- Ying-Hao Shen
- Jia Fan
View Affiliations

Affiliations: Liver Cancer Institute, Zhongshan Hospital, and Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Fudan University, Shanghai 200032, P.R. China
Published online on: November 3, 2016 https://doi.org/10.3892/ijo.2016.3754
Pages: 2367-2376

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Exploring the function of chaperone-mediated autophagy (CMA) in cancer has promoted progress in cancer treatment through the regulation of CMA pathways. However, CMA status and function in hepatocellular carcinoma (HCC) by focusing on the regulatory role of lysosome-associated membrane protein type 2a (Lamp2a) remain to be clarified. We examined Lamp2a in a normal human liver cell line, 6 HCC cell lines, 10 normal liver samples as well as 42 HCC tissue and para-tumor tissues samples, and then validated it in 228 HCC patients to assess the relationship between Lamp2a and clinical prognosis. Gain and loss of Lamp2a function were also explored in HCC cell lines and xenograft models. Significantly lower level of Lamp2a expression was found in HCC cells and tissues compared with normal hepatic cells, para-tumor tissues and normal livers. Although no differences in HCC cell morphology or function were observed in relation to Lamp2a expression under normal culture or short-term starvation conditions, Lamp2a blockage significantly inhibited HCC cell viability under prolonged starvation. Critically, Lamp2a is required for HCC xenograft growth in vivo by helping cells to avoid apoptosis and promoting cell proliferation. Furthermore, a significant correlation between Lamp2a expression and tumor size or cumulative recurrence was uncovered in HCC patients. Collectively, the present study shows that impaired Lamp2a expression in HCC contributes to tumor cell viability and promotes tumor growth and recurrence. Targeting chaperone-mediated autophagy through Lamp2a may also imply a potentially novel treatment strategy for HCC.

View Figures

View References

1	Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
2	Amaravadi RK and Thompson CB: The roles of therapy-induced autophagy and necrosis in cancer treatment. Clin Cancer Res. 13:7271–7279. 2007. View Article : Google Scholar : PubMed/NCBI
3	Kondo Y, Kanzawa T, Sawaya R and Kondo S: The role of autophagy in cancer development and response to therapy. Nat Rev Cancer. 5:726–734. 2005. View Article : Google Scholar : PubMed/NCBI
4	Lee YJ and Jang BK: The role of autophagy in hepatocellular carcinoma. Int J Mol Sci. 16:26629–26643. 2015. View Article : Google Scholar : PubMed/NCBI
5	Amaravadi RK, Lippincott-Schwartz J, Yin XM, Weiss WA, Takebe N, Timmer W, DiPaola RS, Lotze MT and White E: Principles and current strategies for targeting autophagy for cancer treatment. Clin Cancer Res. 17:654–666. 2011. View Article : Google Scholar : PubMed/NCBI
6	Chiang HL and Dice JF: Peptide sequences that target proteins for enhanced degradation during serum withdrawal. J Biol Chem. 263:6797–6805. 1988.PubMed/NCBI
7	Xilouri M, Brekk OR, Kirik D and Stefanis L: LAMP2A as a therapeutic target in Parkinson disease. Autophagy. 9:2166–2168. 2013. View Article : Google Scholar : PubMed/NCBI
8	Fidziańska A, Walczak E and Walski M: Abnormal chaperone-mediated autophagy (CMA) in cardiomyocytes of a boy with Danon disease. Folia Neuropathol. 45:133–139. 2007.
9	Venugopal B, Mesires NT, Kennedy JC, Curcio-Morelli C, Laplante JM, Dice JF and Slaugenhaupt SA: Chaperone-mediated autophagy is defective in mucolipidosis type IV. J Cell Physiol. 219:344–353. 2009. View Article : Google Scholar : PubMed/NCBI
10	Cuervo AM and Dice JF: Regulation of lamp2a levels in the lysosomal membrane. Traffic. 1:570–583. 2000. View Article : Google Scholar
11	Cuervo AM, Knecht E, Terlecky SR and Dice JF: Activation of a selective pathway of lysosomal proteolysis in rat liver by prolonged starvation. Am J Physiol. 269:C1200–C1208. 1995.PubMed/NCBI
12	Cuervo AM and Dice JF: Unique properties of lamp2a compared to other lamp2 isoforms. J Cell Sci. 113:4441–4450. 2000.PubMed/NCBI
13	Park Y, Liu C, Luo T, Dietrich WD, Bramlett H and Hu B: Chaperone-mediated autophagy after traumatic brain injury. J Neurotrauma. 32:1449–1457. 2015. View Article : Google Scholar : PubMed/NCBI
14	Saha T: LAMP2A overexpression in breast tumors promotes cancer cell survival via chaperone-mediated autophagy. Autophagy. 8:1643–1656. 2012. View Article : Google Scholar : PubMed/NCBI
15	Zhang C and Cuervo AM: Restoration of chaperone-mediated autophagy in aging liver improves cellular maintenance and hepatic function. Nat Med. 14:959–965. 2008. View Article : Google Scholar : PubMed/NCBI
16	Ding ZB, Shi YH, Zhou J, Qiu SJ, Xu Y, Dai Z, Shi GM, Wang XY, Ke AW, Wu B, et al: Association of autophagy defect with a malignant phenotype and poor prognosis of hepatocellular carcinoma. Cancer Res. 68:9167–9175. 2008. View Article : Google Scholar : PubMed/NCBI
17	Hui B, Shi YH, Ding ZB, Zhou J, Gu CY, Peng YF, Yang H, Liu WR, Shi GM and Fan J: Proteasome inhibitor interacts synergistically with autophagy inhibitor to suppress proliferation and induce apoptosis in hepatocellular carcinoma. Cancer. 118:5560–5571. 2012. View Article : Google Scholar : PubMed/NCBI
18	Ding ZB, Hui B, Shi YH, Zhou J, Peng YF, Gu CY, Yang H, Shi GM, Ke AW, Wang XY, et al: Autophagy activation in hepatocellular carcinoma contributes to the tolerance of oxaliplatin via reactive oxygen species modulation. Clin Cancer Res. 17:6229–6238. 2011. View Article : Google Scholar : PubMed/NCBI
19	Shi YH, Ding ZB, Zhou J, Hui B, Shi GM, Ke AW, Wang XY, Dai Z, Peng YF, Gu CY, et al: Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosis. Autophagy. 7:1159–1172. 2011. View Article : Google Scholar : PubMed/NCBI
20	Peng YF, Shi YH, Ding ZB, Ke AW, Gu CY, Hui B, Zhou J, Qiu SJ, Dai Z and Fan J: Autophagy inhibition suppresses pulmonary metastasis of HCC in mice via impairing anoikis resistance and colonization of HCC cells. Autophagy. 9:2056–2068. 2013. View Article : Google Scholar : PubMed/NCBI
21	Gao Q, Qiu SJ, Fan J, Zhou J, Wang XY, Xiao YS, Xu Y, Li YW and Tang ZY: Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol. 25:2586–2593. 2007. View Article : Google Scholar : PubMed/NCBI
22	Kaushik S, Bandyopadhyay U, Sridhar S, Kiffin R, Martinez-Vicente M, Kon M, Orenstein SJ, Wong E and Cuervo AM: Chaperone-mediated autophagy at a glance. J Cell Sci. 124:495–499. 2011. View Article : Google Scholar : PubMed/NCBI
23	Lebovitz CB, Bortnik SB and Gorski SM: Here, there be dragons: Charting autophagy-related alterations in human tumors. Clin Cancer Res. 18:1214–1226. 2012. View Article : Google Scholar : PubMed/NCBI
24	Chiang HL, Terlecky SR, Plant CP and Dice JF: A role for a 70-kilodalton heat shock protein in lysosomal degradation of intracellular proteins. Science. 246:382–385. 1989. View Article : Google Scholar : PubMed/NCBI
25	Cuervo AM and Dice JF: A receptor for the selective uptake and degradation of proteins by lysosomes. Science. 273:501–503. 1996. View Article : Google Scholar : PubMed/NCBI
26	Massey AC, Kaushik S, Sovak G, Kiffin R and Cuervo AM: Consequences of the selective blockage of chaperone-mediated autophagy. Proc Natl Acad Sci USA. 103:5805–5810. 2006. View Article : Google Scholar : PubMed/NCBI
27	Schneider JL, Villarroya J, Diaz-Carretero A, Patel B, Urbanska AM, Thi MM, Villarroya F, Santambrogio L and Cuervo AM: Loss of hepatic chaperone-mediated autophagy accelerates proteostasis failure in aging. Aging Cell. 14:249–264. 2015. View Article : Google Scholar : PubMed/NCBI
28	Schneider JL, Suh Y and Cuervo AM: Deficient chaperone-mediated autophagy in liver leads to metabolic dysregulation. Cell Metab. 20:417–432. 2014. View Article : Google Scholar : PubMed/NCBI
29	Finkel T, Serrano M and Blasco MA: The common biology of cancer and ageing. Nature. 448:767–774. 2007. View Article : Google Scholar : PubMed/NCBI
30	Kon M, Kiffin R, Koga H, Chapochnick J, Macian F, Varticovski L and Cuervo AM: Chaperone-mediated autophagy is required for tumor growth. Sci Transl Med. 3:109ra1172011. View Article : Google Scholar : PubMed/NCBI
31	Zhou J, Yang J, Fan X, Hu S, Zhou F, Dong J, Zhang S, Shang Y, Jiang X, Guo H, et al: Chaperone-mediated autophagy regulates proliferation by targeting RND3 in gastric cancer. Autophagy. 12:515–528. 2016. View Article : Google Scholar : PubMed/NCBI
32	Hait WN, Jin S and Yang JM: A matter of life or death (or both): Understanding autophagy in cancer. Clin Cancer Res. 12:1961–1965. 2006. View Article : Google Scholar : PubMed/NCBI
33	White E and DiPaola RS: The double-edged sword of autophagy modulation in cancer. Clin Cancer Res. 15:5308–5316. 2009. View Article : Google Scholar : PubMed/NCBI
34	Cicchini M, Karantza V and Xia B: Molecular pathways: Autophagy in cancer - a matter of timing and context. Clin Cancer Res. 21:498–504. 2015. View Article : Google Scholar
35	Hubbi ME, Hu H, Kshitiz, Ahmed I, Levchenko A and Semenza GL: Chaperone-mediated autophagy targets hypoxia-inducible factor-1α (HIF-1α) for lysosomal degradation. J Biol Chem. 288:10703–10714. 2013. View Article : Google Scholar : PubMed/NCBI
36	Sherman M: Recurrence of hepatocellular carcinoma. N Engl J Med. 359:2045–2047. 2008. View Article : Google Scholar : PubMed/NCBI